- Preamble [SYSTEM]
- Fund & Investor Interest
- Street Moves
- Solebury Trout Updates
- Market Commentary
- IPO News
- Expert Interactions
- Banker Comments & Notes
- Conference Snippet
- Industry Snippets
- Social Media
- Solebury Trout Talks

IPO News: Filed S-1/A: Pliant Therapeutics Launches 6mm Share IPO with $14-$16 Marketing Range
Pliant Therapeutics
Nasdaq: PLRX
Filing Date: 05/11/20
Launch Date: 05/26/20
Price Range: $14.00 - $16.00
Shares Offered (Pre-Shoe, mm): 6.0
Primary Shares (mm): 6.0
Secondary Shares (mm): 0.0
Amount Offered (@ Midpoint)(mm): $90.0
% Secondary: 0.0%
Shares Outstanding (mm): 31.2
Market Value at IPO Midpoint (mm): $468.6
Offering as % of Market Value: 19.2%
Bookrunners: Citi | Cowen | Piper Sandler
Co-Manager: Needham
Major Holders: Third Rock Ventures | Eventide Asset Management | Redmile Group | Cowen Healthcare Investments | Novartis
Description: Pliant Therapeutics is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis.
Note: Existing shareholder, Novartis has agreed to a purchase $10mm worth of stock at the IPO price in a concurrent private placement | Emerging Growth Company
Reference Link: S-1/A